Seminar Title: “Molecular Investigation in the Development of Biological Drug Products from NMR Spectroscopy”
Tuesday, March 29 from 3:30 – 5:00 – PBB 229 & WebEx
https://uconn-cmr.webex.com/uconn-cmr/j.php?MTID=me5afc56432de651f6c78ce1aa1a642c8
Dr. Su is a Principal Scientist and an analytical lead of biophysical and material characterizations in the department of Analytical Research & Development (ARD) at Merck & Co, Inc. He has received postdoctoral training at MIT (2011-2014) after his Ph.D. at Iowa State University (2006-2011). His research focuses on solid-state NMR (ssNMR) characterization of pharmaceutical materials. His team develops and utilizes advanced ssNMR techniques to investigate the molecular mechanism for understanding delivery and stability of drug substances and products. He has contributed over 90 publications in peer-reviewed journals (H-index = 30) and published international patents (e.g., for Keytruda™ and Islatravir™) on drug developments of therapeutic organics and proteins.
For more information, contact: Xiuling Lu at xiuling.lu@uconn.edu